Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies.
Identifieur interne : 001081 ( PubMed/Curation ); précédent : 001080; suivant : 001082Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies.
Auteurs : Peggy Reiner [France] ; Damien Galanaud ; Gaëlle Leroux ; Marie Vidailhet ; Julien Haroche ; Du Le Thi Huong ; Camille Francès ; Thomas Papo ; Christian De Gennes ; Lucile Musset ; Bertrand Wechsler ; Zahir Amoura ; Jean-Charles Piette ; Nathalie Costedoat-ChalumeauSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2011.
English descriptors
- KwdEn :
- Adolescent, Adult, Antibodies, Antiphospholipid (biosynthesis), Antiphospholipid Syndrome (complications), Antiphospholipid Syndrome (immunology), Antiphospholipid Syndrome (physiopathology), Antipsychotic Agents (therapeutic use), Arteries (physiopathology), Child, Chorea (drug therapy), Chorea (immunology), Chorea (physiopathology), Female, Follow-Up Studies, Humans, Lupus Erythematosus, Systemic (immunology), Lupus Erythematosus, Systemic (physiopathology), Male, Middle Aged, Retrospective Studies, Risk, Steroids (therapeutic use), Thrombosis (immunology), Thrombosis (physiopathology), Time Factors, Treatment Outcome, Young Adult.
- MESH :
- chemical , biosynthesis : Antibodies, Antiphospholipid.
- complications : Antiphospholipid Syndrome.
- drug therapy : Chorea.
- immunology : Antiphospholipid Syndrome, Chorea, Lupus Erythematosus, Systemic, Thrombosis.
- physiopathology : Antiphospholipid Syndrome, Arteries, Chorea, Lupus Erythematosus, Systemic, Thrombosis.
- chemical , therapeutic use : Antipsychotic Agents, Steroids.
- Adolescent, Adult, Child, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Risk, Time Factors, Treatment Outcome, Young Adult.
Abstract
The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long-term outcome.
DOI: 10.1002/mds.23863
PubMed: 21755538
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001081
Links to Exploration step
pubmed:21755538Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies.</title><author><name sortKey="Reiner, Peggy" sort="Reiner, Peggy" uniqKey="Reiner P" first="Peggy" last="Reiner">Peggy Reiner</name><affiliation wicri:level="1"><nlm:affiliation>Service de Neurologie, AP-HP, Hôpital Lariboisière, Paris, France. peggyreiner@yahoo.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Neurologie, AP-HP, Hôpital Lariboisière, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Galanaud, Damien" sort="Galanaud, Damien" uniqKey="Galanaud D" first="Damien" last="Galanaud">Damien Galanaud</name></author><author><name sortKey="Leroux, Gaelle" sort="Leroux, Gaelle" uniqKey="Leroux G" first="Gaëlle" last="Leroux">Gaëlle Leroux</name></author><author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name></author><author><name sortKey="Haroche, Julien" sort="Haroche, Julien" uniqKey="Haroche J" first="Julien" last="Haroche">Julien Haroche</name></author><author><name sortKey="Huong, Du Le Thi" sort="Huong, Du Le Thi" uniqKey="Huong D" first="Du Le Thi" last="Huong">Du Le Thi Huong</name></author><author><name sortKey="Frances, Camille" sort="Frances, Camille" uniqKey="Frances C" first="Camille" last="Francès">Camille Francès</name></author><author><name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name></author><author><name sortKey="De Gennes, Christian" sort="De Gennes, Christian" uniqKey="De Gennes C" first="Christian" last="De Gennes">Christian De Gennes</name></author><author><name sortKey="Musset, Lucile" sort="Musset, Lucile" uniqKey="Musset L" first="Lucile" last="Musset">Lucile Musset</name></author><author><name sortKey="Wechsler, Bertrand" sort="Wechsler, Bertrand" uniqKey="Wechsler B" first="Bertrand" last="Wechsler">Bertrand Wechsler</name></author><author><name sortKey="Amoura, Zahir" sort="Amoura, Zahir" uniqKey="Amoura Z" first="Zahir" last="Amoura">Zahir Amoura</name></author><author><name sortKey="Piette, Jean Charles" sort="Piette, Jean Charles" uniqKey="Piette J" first="Jean-Charles" last="Piette">Jean-Charles Piette</name></author><author><name sortKey="Costedoat Chalumeau, Nathalie" sort="Costedoat Chalumeau, Nathalie" uniqKey="Costedoat Chalumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="doi">10.1002/mds.23863</idno><idno type="RBID">pubmed:21755538</idno><idno type="pmid">21755538</idno><idno type="wicri:Area/PubMed/Corpus">001081</idno><idno type="wicri:Area/PubMed/Curation">001081</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies.</title><author><name sortKey="Reiner, Peggy" sort="Reiner, Peggy" uniqKey="Reiner P" first="Peggy" last="Reiner">Peggy Reiner</name><affiliation wicri:level="1"><nlm:affiliation>Service de Neurologie, AP-HP, Hôpital Lariboisière, Paris, France. peggyreiner@yahoo.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Neurologie, AP-HP, Hôpital Lariboisière, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Galanaud, Damien" sort="Galanaud, Damien" uniqKey="Galanaud D" first="Damien" last="Galanaud">Damien Galanaud</name></author><author><name sortKey="Leroux, Gaelle" sort="Leroux, Gaelle" uniqKey="Leroux G" first="Gaëlle" last="Leroux">Gaëlle Leroux</name></author><author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name></author><author><name sortKey="Haroche, Julien" sort="Haroche, Julien" uniqKey="Haroche J" first="Julien" last="Haroche">Julien Haroche</name></author><author><name sortKey="Huong, Du Le Thi" sort="Huong, Du Le Thi" uniqKey="Huong D" first="Du Le Thi" last="Huong">Du Le Thi Huong</name></author><author><name sortKey="Frances, Camille" sort="Frances, Camille" uniqKey="Frances C" first="Camille" last="Francès">Camille Francès</name></author><author><name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name></author><author><name sortKey="De Gennes, Christian" sort="De Gennes, Christian" uniqKey="De Gennes C" first="Christian" last="De Gennes">Christian De Gennes</name></author><author><name sortKey="Musset, Lucile" sort="Musset, Lucile" uniqKey="Musset L" first="Lucile" last="Musset">Lucile Musset</name></author><author><name sortKey="Wechsler, Bertrand" sort="Wechsler, Bertrand" uniqKey="Wechsler B" first="Bertrand" last="Wechsler">Bertrand Wechsler</name></author><author><name sortKey="Amoura, Zahir" sort="Amoura, Zahir" uniqKey="Amoura Z" first="Zahir" last="Amoura">Zahir Amoura</name></author><author><name sortKey="Piette, Jean Charles" sort="Piette, Jean Charles" uniqKey="Piette J" first="Jean-Charles" last="Piette">Jean-Charles Piette</name></author><author><name sortKey="Costedoat Chalumeau, Nathalie" sort="Costedoat Chalumeau, Nathalie" uniqKey="Costedoat Chalumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antibodies, Antiphospholipid (biosynthesis)</term><term>Antiphospholipid Syndrome (complications)</term><term>Antiphospholipid Syndrome (immunology)</term><term>Antiphospholipid Syndrome (physiopathology)</term><term>Antipsychotic Agents (therapeutic use)</term><term>Arteries (physiopathology)</term><term>Child</term><term>Chorea (drug therapy)</term><term>Chorea (immunology)</term><term>Chorea (physiopathology)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lupus Erythematosus, Systemic (immunology)</term><term>Lupus Erythematosus, Systemic (physiopathology)</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk</term><term>Steroids (therapeutic use)</term><term>Thrombosis (immunology)</term><term>Thrombosis (physiopathology)</term><term>Time Factors</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Antibodies, Antiphospholipid</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Antiphospholipid Syndrome</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Chorea</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Antiphospholipid Syndrome</term><term>Chorea</term><term>Lupus Erythematosus, Systemic</term><term>Thrombosis</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Antiphospholipid Syndrome</term><term>Arteries</term><term>Chorea</term><term>Lupus Erythematosus, Systemic</term><term>Thrombosis</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term><term>Steroids</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk</term><term>Time Factors</term><term>Treatment Outcome</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long-term outcome.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">21755538</PMID><DateCreated><Year>2011</Year><Month>11</Month><Day>23</Day></DateCreated><DateCompleted><Year>2012</Year><Month>04</Month><Day>05</Day></DateCompleted><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>13</Issue><PubDate><Year>2011</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies.</ArticleTitle><Pagination><MedlinePgn>2422-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23863</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long-term outcome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analyzed clinical features, laboratory findings, imaging characteristics, and outcome in a series of 32 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most patients were women (28 of 32), and mean age at onset of chorea was 20.6 (9-62) years. Chorea was inaugural for 28 patients. Improvement was observed with various treatments. During follow-up (12.2 ± 11.3 years), severe manifestations of systemic lupus erythematosus were rare. Antiphospholipid antibodies were repeatedly positive for 90% of the patients. Twelve patients developed arterial thrombosis. Prophylactic treatment with antithrombotic therapy might reduce the risk of further thrombosis (8% versus 57%; P = 0.01). Cardiac valvulopathy occurred in 22 patients during follow-up. Chorea relapsed in 8 cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Chorea had a good outcome in itself. This long-term follow-up shows, for the first time, that these patients have substantial risk for further arterial thrombosis.</AbstractText><CopyrightInformation>Copyright © 2011 Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reiner</LastName><ForeName>Peggy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de Neurologie, AP-HP, Hôpital Lariboisière, Paris, France. peggyreiner@yahoo.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galanaud</LastName><ForeName>Damien</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Leroux</LastName><ForeName>Gaëlle</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Vidailhet</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Haroche</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Huong</LastName><ForeName>Du Le Thi</ForeName><Initials>du LT</Initials></Author><Author ValidYN="Y"><LastName>Francès</LastName><ForeName>Camille</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Papo</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>de Gennes</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Musset</LastName><ForeName>Lucile</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Wechsler</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Amoura</LastName><ForeName>Zahir</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Piette</LastName><ForeName>Jean-Charles</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Costedoat-Chalumeau</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017152">Antibodies, Antiphospholipid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013256">Steroids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D017152">Antibodies, Antiphospholipid</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000096">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016736">Antiphospholipid Syndrome</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014150">Antipsychotic Agents</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001158">Arteries</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D002819">Chorea</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008180">Lupus Erythematosus, Systemic</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013256">Steroids</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013927">Thrombosis</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="aheadofprint"><Year>2011</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23863</ArticleId><ArticleId IdType="pubmed">21755538</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001081 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001081 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:21755538
|texte= Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:21755538" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |